LATEST

'Atrocious' - India captain Shreyas left seething by record T20 defeat●Meta rolls out Muse, a new AI image generator●DIU seeks cheaper drones to carry out Reaper missions●A Plunge on a Glacier Peak Triggered a Precision Chopper Rescue. Here is How Crew Members Pulled It Off.●Estonia and Ukraine sign drone pact to deepen defence industry ties●Oberon at the New Museum Is Manhattan's Most Exciting Restaurant Opening●The fury and heartbreak of Egypt's stunning World Cup collapse●Argentina fans sing and dance after dramatic World Cup comeback against Egypt● 'Atrocious' - India captain Shreyas left seething by record T20 defeat●Meta rolls out Muse, a new AI image generator●DIU seeks cheaper drones to carry out Reaper missions●A Plunge on a Glacier Peak Triggered a Precision Chopper Rescue. Here is How Crew Members Pulled It Off.●Estonia and Ukraine sign drone pact to deepen defence industry ties●Oberon at the New Museum Is Manhattan's Most Exciting Restaurant Opening●The fury and heartbreak of Egypt's stunning World Cup collapse●Argentina fans sing and dance after dramatic World Cup comeback against Egypt●

Longevity

World’s first in vivo gene editing Phase 3 win

Longevity.Technology 18 June 2026, 16:43 UTC 18 Jun 2026

World’s first in vivo gene editing Phase 3 win — Longevity.Technology

A one-time CRISPR treatment dramatically reduced attacks in hereditary angioedema, marking a major milestone for genetic medicine. Gene editing has been generating headlines, hope and skepticism in roughly equal measure. Last weekend, it delivered something tangible: a Phase 3 clinical success. Intellia Therapeutics announced additional positive results from its HAELO Phase 3 trial of lonvoguran […] The post World’s first in vivo gene editing Phase 3 win appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.

Read full coverage at Longevity.Technology →

More from Longevity

LG AI, D&D Pharmatech push AI-powered peptide drug discovery

Longevity.Technology · 5h ago

Rescuing Calcium Ion Homeostasis Extends Mouse Lifespan

Lifespan Research Institute · 6h ago

BioAge advances inflammaging drug into Phase 2

Longevity.Technology · 6h ago

AI-designed IPF drug advances to Phase III

Longevity.Technology · 9h ago

How Muscle Loss and Bone Loss Are Related

Lifespan Research Institute · 1d ago

RNA, AI and the end of one-size-fits-all nutrition

Longevity.Technology · 1d ago